Timelines for acceptance of CE marked medical devices in Great Britain (GB)

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a public consultation regarding the indefinite recognition of CE-marked medical devices within the Great Britain (GB) market. This proposal marks a significant shift in the regulatory framework, moving toward a permanent acceptance of European conformity markings rather than relying on time-limited transition periods. The consultation is scheduled to take place from February 16, 2026, to April 10, 2026. During this period, existing transition arrangements will remain fully operational to ensure market stability and the continued availability of essential medical products. While the provided text does not detail specific company inspections or individual violations—as it focuses on national policy updates rather than enforcement actions—it serves as a critical update for all manufacturers operating under the Medical Devices Regulations 2002. Affected stakeholders and industry participants are required to review the proposed changes and submit their formal feedback within the specified timeframe. This input will inform the final regulatory structure for medical device safety and compliance in the UK. Manufacturers and suppliers should continue to follow current guidance and maintain compliance with existing standards until the MHRA issues a formal response and potential legislative amendments following the conclusion of the consultation process.